Influence of dose engine accuracy on the optimum dose distribution in intensity-modulated proton therapy treatment plans

2007 ◽  
Vol 52 (3) ◽  
pp. 725-740 ◽  
Author(s):  
Martin Soukup ◽  
Markus Alber
2016 ◽  
Vol 3 (2) ◽  
pp. 305-311 ◽  
Author(s):  
Li Liao ◽  
Gino J. Lim ◽  
Yupeng Li ◽  
Juan Yu ◽  
Narayan Sahoo ◽  
...  

Abstract We have developed a robust optimization approach for intensity modulated proton therapy treatment plans with multi-isocenter large fields. The method creates a low-gradient field dose in the junction regions to mitigate the impact caused by misalignment errors and is more efficient than the conventional junction shifting technique.


2021 ◽  
Vol 81 ◽  
pp. 77-85
Author(s):  
Yihang Xu ◽  
Tejan Diwanji ◽  
Nellie Brovold ◽  
Michael Butkus ◽  
Kyle R. Padgett ◽  
...  

2008 ◽  
Vol 35 (3) ◽  
pp. 1103-1112 ◽  
Author(s):  
Haisen S. Li ◽  
H. Edwin Romeijn ◽  
Christopher Fox ◽  
Jatinder R. Palta ◽  
James F. Dempsey

2015 ◽  
Vol 18 (3) ◽  
pp. 93-100
Author(s):  
Tu Thi Cam Nguyen ◽  
Nhon Van Mai ◽  
Binh Thai Nguyen

Nowadays, traditional radiation therapy using x-rays is still the most common type of external exposure in curing cancer. However, the persisting problem is that significant dose delivered to normal tissues because of the characteristics of interaction of photons with matter even with the most advanced delivery techniques such as IMRT, IGRT, etc. Proton therapy is not only the technique producing better conformity to target but also better sparing to organs at risk. In this work, intensity modulated proton therapy (IMPT) and intensity modulated photon therapy (IMRT) plans are generated for a prostate patient. The evaluation and comparison of the two treatment plans were performed in term of physical quantity based on Dose Volume Histogram (DVH) and dose statistics for both target and organs at risk. The results of our study show that IMPT could be beneficial compared to IMRT with 5 fields. The doses to intestine and bladder are low resulting in possibly reducing side effects and second malignancies


Sign in / Sign up

Export Citation Format

Share Document